Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 292–292 | Cite as

Ipilimumab/nivolumab

Hepatitis: case report
Case report
  • 9 Downloads

Reference

  1. Park S, et al. Safety and efficacy of checkpoint inhibition (CI) in cancer patients (pts) with concurrent human immunodeficiency virus (HIV) infection. Journal of Clinical Oncology 36 (Suppl. 1): no pagination abstr. 136, No. 5, Feb 2018. Available from: URL: http://doi.org/10.1200/JCO.2018.36.5_suppl.136 [abstract] - USA

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations